Dr. Srinivas Chilukuri is a key opinion leader in the field of radiation oncology in India. He is credited with pioneering Southeast Asia\u2019s first clinical programme for particle beam therapy at Apollo Proton Cancer Centre, Chennai, India, where he continues to lead the pediatric, bone, soft tissue, genitourinary, and thoracic cancer radiation oncology programme. Apart from delivering clinical service, he is currently running several prospective studies, including collaborative research with some of the finest institutions in the world. He also sits on several prestigious national and international panels formulating guidance papers and advises governmental agencies, such as the World Economic Forum.<\/p>\n
He is also the co-founding chairman of Optimus Oncology, a healthcare start-up providing modern and affordable cancer care in rural pockets of India. It has attracted funding of 5 million USD in the first 3 years of its operations and is currently serving 5 districts in rural Maharashtra, India. The centres have treated more than 20,000 patients so far since inception and are on the cusp of a massive expansion.<\/p>\n
In 2009, he is also credited with initiating the first clinical programme utilizing volumetric modulated arc therapy in the sub-continent and has been the clinical lead of the Advanced Radiotherapy School. Through this school, which was run in collaboration with Varian Medical Systems, he has trained more than 200 radiation oncologists and medical physicists from Asia and Africa over more than 7 years. He has also been a popular teacher and has trained several postgraduate students in radiation oncology under his mentorship.<\/p>\n
Dr. Chilukuri was trained at some of the finest institutions, such as Armed Forces Medical College and Tata Memorial Hospital, and had exposure to leading global institutions, including Miami Cancer Institute and Mayo Clinic, through short clinical training programmes and fellowships. He has been awarded fellowships by the American Society of Oncology and the European Society of Medical Oncology for being one of the most promising oncologists. He has won several national and international awards and has numerous international scientific publications to his credit, including in high-impact journals.<\/p>\n
Apollo Proton Cancer Centre, Chennai, India (Since 15 th March 2018)<\/strong> Yashoda Multispeciality Hospitals and Cancer Institute, Hyderabad, India.<\/strong> Varian Medical Systems, Palo Alto, California, USA<\/strong> Tata Memorial Hospital, Mumbai, India<\/strong> 1. Apollo Clinical Excellence award: Best Clinical Academician for the year 2020 from Apollo Healthcare enterprise limited. Recent Publications (in the last 5 years)<\/strong><\/p>\n 1. Chilukuri S, Burela N, Sundar S, Kamath R, Nangia S, Arjunan M, Kumar R, Ramanujam V, Chacko A, Sharma DS, Jalali R. Impact of Dosimetric Compromises on Early Outcomes of Chordomas and Chondrosarcomas Treated with Image-guided Pencil Beam Scanning Proton Beam Therapy. Adv Radiat Oncol. 2024 Jul 28;9(10):101582. 11. Chilukuri S, Panda PK, Jalali R. Proton Therapy in LMICs: Is the Need Justified? JCO Glob Oncol. 2022 Jan;8:e2100268. 34. Rishan TS, Chilukuri S, et al. Introduction of proton beam therapy in intracranial germ cell tumors in India-initial experience. Indian Pediatrics. 2021 Accepted for publication.<\/p>\n","protected":false},"excerpt":{"rendered":" Dr. Srinivas Chilukuri is a key opinion leader in the field of He is also the co-founding chairman of Optimus Oncology, which is a healthcare start-up providing
\n1. Professor and Lead Consultant Radiation Oncologist
\n2. Radiation Oncology Lead for Pediatric\/Bone\/Soft-tissue, Genitourinary and Thoracic Cancer management team.
\nOptimus Oncology (since 1 st October 2016)<\/strong>
\n1. Co-founder and Chairman- currently has 5 oncology centres in Latur, Solapur, Akola, Dhule and Nashik.<\/p>\nPrevious Professional Attachments<\/h3>\n
\n1. Senior Consultant, Department of Radiation Oncology since July 2008.
\n2. Academic Lead, Department of Radiation Oncology. 16 students have been trained and received DNB Radiation Oncology under my supervision.
\n3. Clinical Lead of Varian Advanced Radiotherapy school- trained more than 200 radiation oncologists and medical physicist in IMRT, IGRT, VMAT, respiratory gating and other technical aspects of high precision radiation therapy.
\n4. Clinical Director of YIROS- led the project to commission, initiate and establishment of clinical radiation oncology programme at Siloam Hospitals in Jakarta, Indonesia.<\/p>\n
\n1. Consultant Clinical Affairs in Asia Pacific region from May 2017 till April 2019.<\/p>\n
\n1. Senior Resident, Department of Radiation Oncology from April 2006 till June 2007.<\/p>\nAwards Received<\/h3>\n
\n2. International Development and Education Award (IDEA)<\/strong> by American Society of Clinical Oncology-Conquer Cancer Foundation in year 2013.
\n3. \u201cDeveloping Nations Travel Grant\u201d<\/strong> to attend World GI Cancer Conference held at Barcelona in June 2016 and 2007.
\n4. Topped Mumbai University MD Radiation Oncology examination.
\n5. Indian College of Radiation Oncology (ICRO)-\u201cYoung Achiever Award\u201d- For standing first at Annual Teaching Course in September 2006
\n6. Winner of National level Annual Oncology Quiz held at AROICON 2006.
\n7. Best Poster Award at Association Of Radiation Oncologists Of India at AROICON 2005.
\n8. \u201cResearch and Education Grant\u201d to attend and present Thesis at Joint meeting of Royal College of Radiologists and Hong Kong college of Radiologists at Hong Kong in October 2007.
\n9. ESTRO Travel Grant for \u201cIGRT\u201d and \u201cIMRT and other Conformal Techniques\u201d Teaching Courses in Dec 2008 and June 2007 respectively.<\/p>\nPeer-reviewed Research Publications:<\/h3>\n
\n2. Das A, Gaikwad U, Krishnan G, Rajendran A, Patil S, Subramaniam P, Krishna U, Wakde MG, Chilukuri S, Jalali R. Successful Implementation of Image-Guided Pencil-Beam Scanning Proton Therapy in Medulloblastomas. Diagnostics (Basel). 2023 Nov 3;13(21):3378.
\n3. Rajendran A, Natesan C, Jawahar P, Patil S, Chilukuri S, Ghosh S, Kumar R, Jalali R. Amide proton transfer imaging-arterial spin labeling mismatch: a new imaging biomarker for pilocytic astrocytoma. Sci Rep. 2023 Sep 29;13(1):16377.
\n4. Burela N, Das A, Krishnan G, Rajendran A, Chilukuri S, Kumar Vr R, Deopujari CE, Sharma DS, Jalali R. Encouraging Experience with Image-Guided Pencil Beam Scanning Proton Therapy in Craniopharyngioma-First Case Series From India. World Neurosurg. 2024 May;185:e407- e414.
\n5. Banerjee A, Babu R, Jayaraman D, Chilukuri S. Preoperative three-dimensional modelling and virtual reality planning aids nephron sparing surgery in a child with bilateral Wilms tumour. BMJ Case Rep. 2024 Apr 19;17(4):e260600.
\n6. Nangia S, Gaikwad U, Joshua P, Mookaiah M, Burela N, Thirumalai A, Chilukuri S, Gayen S, Karra AR, Sharma DS. Dosimetric benefits of customised mouth-bite for head neck cancer patients undergoing modern proton therapy – An audit. Tech Innov Patient Support Radiat Oncol. 2024 Jul 31;31:100265.
\n7. Biswas B, Talwar D, Meshram P, Julka PK, Mehta A, Somashekhar SP, Chilukuri S, Bansal A. Navigating patient journey in early diagnosis of lung cancer in India. Lung India. 2023 Jan- Feb;40(1):48-58. doi: 10.4103\/lungindia.lungindia_144_22.
\n8. Murthy V, Chilukuri S, Maitre P. Let\u2019s not forget local treatment intensification. European Urology 2022,82:82-96.
\n9. Chilukuri S, Sundar S, Patro K, Sawant M, Sivaraman R, Arjunan M, Panda PK, Sharma D, Jalali R. Comparison of Estimated Late Toxicities between IMPT and IMRT Based on Multivariable NTCP Models for High-Risk Prostate Cancers Treated with Pelvic Nodal Radiation. Int J Part Ther. 2022 Jun 13;9(1):42-53.
\n10. Chilukuri S, Murthy V. Adjuvant radiation for prostate cancer: too early to abandon? BJU Int. 2021 Jul;128(1):23-24.<\/p>\n
\n12. Nangia S, Gaikwad U, Noufal MP, Chilukuri S, Patro K, Nakra V, Panda PK, Mathew AS, Sharma DS, Jalali R. Proton therapy for skull-base adenoid cystic carcinomas: A case series and review of literature. J Cancer Res Ther. 2022 Apr-Jun;18(3):629-637.
\n13. Gaikwad U, Mookaiah M, Karthekeyan S, Wakde M, Noufal MP, Chilukuri S, Sharma D, Jalali R, Nangia S. Standard Operating Procedure (SOP) for mould room practices and simulation of head neck cancer patients undergoing proton therapy. Tech Innov Patient Support Radiat Oncol. 2022 Sep 30;24:48-53.
\n14. Nangia S, Gaikwad U, Noufal MP, Sawant M, Wakde M, Mathew A, Chilukuri S, Sharma D, Jalali R. Proton therapy and oral mucositis in oral & oropharyngeal cancers: outcomes, dosimetric and NTCP benefit. Radiat Oncol. 2023 Jul 19;18(1):121.
\n15. Arjunan M, Krishnan G, Sharma DS, M P N, Patro KC, Thiyagarajan R, Srinivas C, Jalali R. Dosimetric impact of random spot positioning errors in intensity modulated proton therapy plans of small and large volume tumors. Br J Radiol. 2021 Mar 1;94(1119):20201031.
\n16. Chilukuri S, Burela N, Uppuluri R, Indumathi D, Nangia S, Panda PK, Shamurailatpam DS, Raj R, Raja T, Jalali R. Preliminary Experience of Treating Children and Young Adults With Image- Guided Proton Beam Therapy in India. JCO Glob Oncol. 2020\u00a0Nov;6:1736-1745.
\n17. Chilukuri S, Burela N. Memantine for Prevention of Brain Irradiation-Induced Cognitive Toxicity: A Tale of an Underappreciated and Underused Intervention. JCO Glob Oncol. 2020 Sep;6:1384-1388.
\n18. Chilukuri S, Sundar S, Thiyagarajan R, Easow J, Sawant M, Krishanan G, Panda PK, Sharma D, Jalali R. Total marrow and lymphoid irradiation with helical tomotherapy: a practical implementation report. Radiat Oncol J. 2020 Sep;38(3):207-216.
\n19. Chilukuri S, Rakesh Jalali, Reassuring quality of life in younger childhood (<4 years) brain tumor survivors treated with proton beam therapy,\u00a0Neuro-Oncology, noaa173.
\n20. Chilukuri S., Panda, P.K. & Jalali, R. PITChing (professional organisations, innovative trial designs and collaborative approach) for evidence generation for proton therapy.\u00a0Radiat Oncol\u00a015,\u00a0138 (2020).
\n21. Chilukuri S, Sham C Sundar, Pankaj Kumar Panda. The toxicity data from POP-RT: Proving the \u201cObvious\u201d and challenging the \u201cNorm\u201d. Radiotherapy Oncology 2020;147,247.
\n22. Chilukuri S, Jalali R. Brain metastasis: Momentum towards understanding the molecular milieu. Neurol India. 2019 May-Jun;67(3):755-756.
\n23. Chilukuri S, Jalali R. Risk of second malignancy after modern conformal and proton beam radiotherapy-Minimizing risks, improving survivorship. Indian J Cancer. 2018 Oct- Dec;55(4):316-317.
\n24. Rishan TS, Chilukuri S, et al. Introduction of proton beam therapy in intracranial germ cell tumors in India-initial experience. Indian Pediatrics. 2021 Accepted for publication.
\n25. Tonse R, Chilukuri S, Shamurailatpam D,\u00a0Jalali R. Introduction of ImageGuided\u00a0Pencil Beam for Skull Base Tumors in India: A Report of Two Cases and a Brief Review of the Literature. Neurol India. 2020 Jan-Feb;68(1):42-44. doi:\u00a010.4103\/0028-3886.279680.
\n26. Tonse R, Chilukuri S, Shamurailatpam D, Jalali R. Introduction of ImageGuided Pencil Beam for Skull Base Tumors in India: A Report of Two Cases and a Brief Review of the Literature. Neurol India. 2020 Jan-Feb;68(1):42-44.
\n27. Sudarsan RT, Chilukuri S, Noufal MP, Adhithyan R, Uppuluri R, Panda PK, Patil S, Sharma D, Roopesh Kumar VR, Jalali R. EPEN-22. Molecularly aggressive ependymomas treated with Image guided pencil beam proton therapy: consecutive patient Indian experience. Neuro Oncol. 2022 Jun 3;24(Suppl 1):i43.
\n28. Murugesan A, Raghuraman MS, Chilukuri S, Raja T. Hydro-dissection of Dorsal Scapular Nerve for Neuropathy Post Radical Neck Dissection and Radiation: A Case Report. Indian J Palliat Care. 2021 Oct-Dec;27(4):577-579.
\n29. Sudarsan RT, Chilukuri S, Padannayil NM, Panda PK, Jalali R. Introduction of Proton Beam Therapy in Intracranial Germ Cell Tumors in India. Indian Pediatr. 2021 Feb 15;58(2):182- 183.
\n30. Ghadyalpatil NS, Pandey A, Krishnamani I, Srinivas C, Rafiq SJ, Hingmire SS, Maturu N, Reddy R, Kumar KK, Sreekanth K, Gurram BC, Parikh PM. First-line management of metastatic non- small cell lung cancer: An Indian perspective. South Asian J Cancer. 2019 Apr-Jun;8(2):73-79
\n31. Arjunan M, Krishnan G, Sharma DS, M P N, Patro KC, Thiyagarajan R, Srinivas C, Jalali R. Dosimetric impact of random spot positioning errors in intensity modulated proton therapy plans of small and large volume tumors. Br J Radiol. 2021 Mar 1;94(1119):20201031.
\n32. Thiyagarajan R, Sharma DS, Kaushik S, Sawant M, Ganapathy K, Nambi Raj NA, Chilukuri S, Sundar SC, Patro KC, Manikandan A, Noufal MP, Sivaraman R, Easow J, Jalali R. Leaf open time sinogram (LOTS): a novel approach for patient specific quality assurance of total marrow irradiation. Radiat Oncol. 2020 Oct 14;15(1):236.
\n33. Sharma DS, Patro KC, Manthala Padannayel N, Chilukuri S et al. Ambient neutron and photon dose equivalent H*(10) around a pencil beam scanning proton therapy facility.\u00a0Br J Radiol. 2019;92(1102):20190382.<\/p>\n
\nradiation oncology in India. He is credited with pioneering
\nsoutheast Asia\u2019s first clinical programme for particle beam
\ntherapy at Apollo Proton Cancer Centre, Chennai, India where he
\ncontinues to lead pediatric\/bone\/soft tissue, genitourinary and
\nthoracic cancer radiation oncology programme. Apart from
\ndelivering clinical service, he is currently running several prospective studies including collaborative
\nresearch with some of the finest institutions of the world. He also sits on several prestigious national
\nand international panels formulating guidance papers and advises governmental and agencies such
\nas World Economic Forum.<\/p>\n
\nmodern and affordable cancer care in rural pockets of India. It has attracted funding of 5million USD
\nin the first 3 years of its operations and is currently serving 5 districts in rural Maharashtra, India.
\nThe centres have treated more than 20,000 patients so far since inception and is on the cusp of a
\nmassive expansion.<\/p>\n","protected":false},"author":1,"featured_media":1151,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-610","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/digitalviewindia.in\/demo\/websites\/dr_srinivas\/wp-json\/wp\/v2\/pages\/610","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/digitalviewindia.in\/demo\/websites\/dr_srinivas\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/digitalviewindia.in\/demo\/websites\/dr_srinivas\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/digitalviewindia.in\/demo\/websites\/dr_srinivas\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/digitalviewindia.in\/demo\/websites\/dr_srinivas\/wp-json\/wp\/v2\/comments?post=610"}],"version-history":[{"count":38,"href":"https:\/\/digitalviewindia.in\/demo\/websites\/dr_srinivas\/wp-json\/wp\/v2\/pages\/610\/revisions"}],"predecessor-version":[{"id":1156,"href":"https:\/\/digitalviewindia.in\/demo\/websites\/dr_srinivas\/wp-json\/wp\/v2\/pages\/610\/revisions\/1156"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/digitalviewindia.in\/demo\/websites\/dr_srinivas\/wp-json\/wp\/v2\/media\/1151"}],"wp:attachment":[{"href":"https:\/\/digitalviewindia.in\/demo\/websites\/dr_srinivas\/wp-json\/wp\/v2\/media?parent=610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}